$1.76 -0.01 (-0.57%) Genetic Tech Shs Sponsored American Deposit Receipt Repr 150 Shs - NASDAQ

Sep. 30, 2016 | 04:00 PM
Last Trade: 1.76
Trade Time: Sep 30 04:00 PM Eastern Daylight Time
Change: -0.01 (-0.57%)
Prev Close: 1.77
Open: 1.76
Bid: 1.75
Ask: 1.77
  1. No results found.
  1. Genetic Technologies Announces Settlement and Release Agreement With Hendrix Genetics

    Benzinga | Feb. 5, 2016 | 04:40AM EST
  2. Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of ...

    GuruFocus | Dec. 21, 2015 | 23:06PM EST
  3. Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of BREVAGenplus

    Benzinga | Dec. 21, 2015 | 05:48AM EST
  4. BREVAGenplus(R) Offers a Solution to Physicians Concerned About the Revised Breast Cancer Screening Guidelines from the American Cancer Society (ACS)

    Benzinga | Nov. 2, 2015 | 10:36AM EST
  5. Genetic Technologies Granted Key Patents by US Patent Office for BREVAGenplus(R)

    GuruFocus | Aug. 7, 2015 | 00:04AM EST
  6. Genetic Technologies Granted Key Patents by US Patent Office for BREVAGenplus

    Benzinga | Aug. 6, 2015 | 05:31AM EST
  7. Genetic Technologies Announces Scientific Validation, Clinical Trial and Peer Review ...

    GuruFocus | Jul. 15, 2015 | 00:02AM EST
  8. Morning Market Gainers

    Benzinga | Apr. 20, 2015 | 09:41AM EST
  9. Genetic Technologies Reports Additional Breast Health Centres to Begin Offering Brevagenplus

    Benzinga | Apr. 20, 2015 | 05:31AM EST
  10. Biotech Stocks Moving Higher

    Benzinga | Feb. 23, 2015 | 15:35PM EST
  11. Stock Futures Show Mild Losses; Boston Scientific Bolts Higher

    IBD | Feb. 18, 2015 | 09:16AM EST
  12. Morning Market Gainers

    Benzinga | Jan. 29, 2015 | 09:46AM EST
  13. Clinical Validation Study Supporting the Use of BREVAGenplus(R) in Breast Cancer Risk Assessment

    GuruFocus | Dec. 17, 2014 | 11:03AM EST
  14. Genetic Technologies Announces Clinical Validation Study Supporting the Use of BREVAGenplus in Breast Cancer Risk Assessment

    Benzinga | Dec. 17, 2014 | 05:56AM EST
  15. Genetic Technologies Launches BREVAGenplus(R) Breast Cancer Risk Assessment Test

    GuruFocus | Oct. 15, 2014 | 12:51PM EST
Trading Center